SCHEMBL3481736

SCHEMBL3481736

COc1ccc2nc(NCC(=O)N(C)C)c(C#N)c(-c3cccc(Cl)c3)c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.44
NPSR1 Q6W5P4 2/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
GSR P00390 4/20 0.40
MAT2A P31153 1/20 0.40
KCNA5 P22460 2/20 0.38
ADORA2A P29274 2/20 0.38
ADORA1 P30542 1/20 0.38
KCNH2 Q12809 1/20 0.38
PDE10A Q9Y233 1/20 0.38
MAPT P10636 1/20 0.38
CDK2 P24941 1/20 0.38
CLK1 P49759 1/20 0.38
PLA2G2A P14555 1/20 0.37
GRIA2 P42262 1/20 0.37
GRIA4 P48058 1/20 0.37
ABCC8 Q09428 1/20 0.37
KCNJ11 Q14654 1/20 0.37
PGK1 P00558 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2168526 0.85 ADORA2A (0.48) KDM4ENPSR1ALDH1A1GSRKCNA5
SCHEMBL3482220 0.81 KDM4E (0.43) KDM4EALDH1A1LMNAGSRKCNA5
Hydrochloric Acid SCHEMBL3481371 0.81 KDM4E (0.41) KDM4ENPSR1ALDH1A1LMNAGSR
SCHEMBL3481836 0.79 KDM4E (0.53) KDM4ENPSR1ALDH1A1LMNAADORA2A
SCHEMBL2168476 0.78 KDM4E (0.57) KDM4ENPSR1ALDH1A1ADORA2AADORA1
SCHEMBL3482013 0.77 KDM4E (0.56) KDM4ENPSR1ALDH1A1ADORA2AADORA1
SCHEMBL13401016 0.77 KDM4E (0.56) KDM4ENPSR1ALDH1A1ADORA2AADORA1
SCHEMBL2171286 0.77 MAPT (0.54) KDM4ENPSR1ALDH1A1LMNAMAPT
SCHEMBL3481271 0.76 KDM4E (0.55) KDM4ENPSR1ALDH1A1ADORA2AADORA1
SCHEMBL3481335 0.73 MAPT (0.51) KDM4ENPSR1ALDH1A1LMNAADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7692017-B2 Quinoline potassium channel inhibitors MERCK SHARP & DOHME CORP. (US) 2010-04-06 US disclosed
US-20070043042-A1 Such as 2-(Allyloxy)-4-(3-fluorophenyl)-6-methoxyquinoline-3-carbonitrile; for treating cardiac arrhthymias MERCK & CO., INC. (US) 2007-02-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043042-A1 Such as 2-(Allyloxy)-4-(3-fluorophenyl)-6-methoxyquinoline-3-carbonitrile; for treating cardiac arrhthymias KCNH2, KCNJ2, KCNQ1 KDM4E 1076/4885NPSR1 1740/4885ALDH1A1 260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.